COVID-19 Virus-Killing Nanofiber Materials

Overview

NAMI has developed an antiviral nanofiber material killing COVID-19 virus.

Commercialisation opportunities

Non-exclusive licensing

Problem addressed

Most facemasks in the market only act as a physical barrier to prevent the entrance of airborne contaminants like bacteria or viruses into human bodies. Those contaminants retained inside the facemasks may lead to secondary exposure if the facemasks are not properly handled after use. NAMI has developed antiviral nanofiber materials with negligible effect on air permeability, upgrading common facemasks.

Innovation

Certified by Bioscience Laboratories in the U.S., this nanofiber material offers robust antiviral efficiency against SARS-CoV-2, the virus that causes COVID-19.
Common facemasks can be upgraded with such antiviral nanofiber layer for extra protection.

Key impact

Effective antiviral function
Negligible effect on facemask’s breathability
Safe to user
Scalable production

Application

Facemasks with upgraded protection

Website

Nano and Advanced Materials Institute (NAMI)

As a Materials Expert, Nano and Advanced Materials Institute (NAMI) has a strong portfolio of innovative technologies to support and collaborate with the industry, offering frontier-applied research on advanced materials as well as technology transfer for commercialization success.

NAMI, incorporated in 2006, is designated by the Innovation and Technology Commission of the Hong Kong Government as a Research and Development Center for nanotechnology and advanced materials. NAMI undertakes and provides support for market-driven research in nanotechnology and advanced materials, and strives for commercialization of the technologies to benefit the industry and the society at large, as well as re-industrialization to promote the economic growth and sustainability of Hong Kong.

Enquiry